Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis

Neuron ◽  
1993 ◽  
Vol 10 (4) ◽  
pp. 667-678 ◽  
Author(s):  
Theodore R. Cummins ◽  
Jiuying Zhou ◽  
Frederick J. Sigworth ◽  
Chinwe Ukomadu ◽  
Megan Stephan ◽  
...  
1996 ◽  
Vol 497 (2) ◽  
pp. 349-364 ◽  
Author(s):  
W J Hanna ◽  
R G Tsushima ◽  
R Sah ◽  
L J McCutcheon ◽  
E Marban ◽  
...  

2001 ◽  
Vol 248 (11) ◽  
pp. 1003-1004 ◽  
Author(s):  
Shiho Okuda ◽  
Fumio Kanda ◽  
Keisuke Nishimoto ◽  
Ryogen Sasaki ◽  
Kazuo Chihara

1999 ◽  
Vol 276 (1) ◽  
pp. C259-C266 ◽  
Author(s):  
Cecilia V. Rojas ◽  
Alan Neely ◽  
Gabriela Velasco-Loyden ◽  
Verónica Palma ◽  
Manuel Kukuljan

Mutations in the human skeletal muscle Na+ channel underlie the autosomal dominant disease hyperkalemic periodic paralysis (HPP). Muscle fibers from affected individuals exhibit sustained Na+ currents thought to depolarize the sarcolemma and thus inactivate normal Na+ channels. We expressed human wild-type or M1592V mutant α-subunits with the β1-subunit in Xenopus laevis oocytes and recorded Na+ currents using two-electrode and cut-open oocyte voltage-clamp techniques. The most prominent functional difference between M1592V mutant and wild-type channels is a 5- to 10-mV shift in the hyperpolarized direction of the steady-state activation curve. The shift in the activation curve for the mutant results in a larger overlap with the inactivation curve than that observed for wild-type channels. Accordingly, the current through M1592V channels displays a larger noninactivating component than does that through wild-type channels at membrane potentials near −40 mV. The functional properties of the M1592V mutant resemble those of the previously characterized HPP T704M mutant. Both clinically similar phenotypes arise from mutations located at a distance from the putative voltage sensor of the channel.


1995 ◽  
Vol 73 (5) ◽  
pp. 1892-1899 ◽  
Author(s):  
S. C. Cannon ◽  
L. J. Hayward ◽  
J. Beech ◽  
R. H. Brown

1. Equine hyperkalemic periodic paralysis (E-HPP) is a dominantly inherited disorder of muscle that causes recurrent episodes of stiffness (myotonia) and weakness in association with elevated serum K+. Affected horses carry a mutant allele of the skeletal muscle isoform of the Na channel alpha-subunit. To understand how this mutation may cause the disease phenotype, the functional defect in Na channel behavior was defined physiologically by recording unitary currents from cell-attached patches on normal and affected equine myotubes. 2. The presence of the mutation was confirmed in our cell line by restriction digest of polymerase chain reaction (PCR)-amplified genomic DNA. Myotubes from the affected horse were heterozygous for the point mutation that codes for a Phe to Leu substitution in S3 of domain IV. This assay provides a rapid technique to screen for the mutation in horses at risk. 3. The primary physiological defect in mutant Na channels was an impairment of inactivation. This defect was manifest as bursts of persistent activity during which the channel closed and reopened throughout a maintained depolarization. Disrupted inactivation slowed the decay of the ensemble-averaged current and produced an eightfold increase in the steady-state open probability measured at the end of a 40-ms pulse. This point mutation identifies a new region of the alpha subunit that is important for rapid inactivation of the channel. 4. The persistent Na current was produced by a distinct mode of gating. Failure of a mutant channel to inactivate was infrequent and occurred in groups of consecutive trials.(ABSTRACT TRUNCATED AT 250 WORDS)


1995 ◽  
Vol 37 (3) ◽  
pp. 408-411 ◽  
Author(s):  
Jaime L. Baquero ◽  
Ricardo A. Ayala ◽  
Jianzhou Wang ◽  
Richard G. Curless ◽  
W. Gregory Feero ◽  
...  

2011 ◽  
Vol 138 (1) ◽  
pp. 117-130 ◽  
Author(s):  
Torben Clausen ◽  
Ole Bækgaard Nielsen ◽  
Johannes D. Clausen ◽  
Thomas Holm Pedersen ◽  
Lawrence J. Hayward

In patients with hyperkalemic periodic paralysis (HyperKPP), attacks of muscle weakness or paralysis are triggered by K+ ingestion or rest after exercise. Force can be restored by muscle work or treatment with β2-adrenoceptor agonists. A missense substitution corresponding to a mutation in the skeletal muscle voltage-gated Na+ channel (Nav1.4, Met1592Val) causing human HyperKPP was targeted into the mouse SCN4A gene (mutants). In soleus muscles prepared from these mutant mice, twitch, tetanic force, and endurance were markedly reduced compared with soleus from wild type (WT), reflecting impaired excitability. In mutant soleus, contractility was considerably more sensitive than WT soleus to inhibition by elevated [K+]o. In resting mutant soleus, tetrodotoxin (TTX)-suppressible 22Na uptake and [Na+]i were increased by 470 and 58%, respectively, and membrane potential was depolarized (by 16 mV, P < 0.0001) and repolarized by TTX. Na+,K+ pump–mediated 86Rb uptake was 83% larger than in WT. Salbutamol stimulated 86Rb uptake and reduced [Na+]i both in mutant and WT soleus. Stimulating Na+,K+ pumps with salbutamol restored force in mutant soleus and extensor digitorum longus (EDL). Increasing [Na+]i with monensin also restored force in soleus. In soleus, EDL, and tibialis anterior muscles of mutant mice, the content of Na+,K+ pumps was 28, 62, and 33% higher than in WT, respectively, possibly reflecting the stimulating effect of elevated [Na+]i on the synthesis of Na+,K+ pumps. The results confirm that the functional disorders of skeletal muscles in HyperKPP are secondary to increased Na+ influx and show that contractility can be restored by acute stimulation of the Na+,K+ pumps. Calcitonin gene-related peptide (CGRP) restored force in mutant soleus but caused no detectable increase in 86Rb uptake. Repeated excitation and capsaicin also restored contractility, possibly because of the release of endogenous CGRP from nerve endings in the isolated muscles. These observations may explain how mild exercise helps locally to prevent severe weakness during an attack of HyperKPP.


BMJ ◽  
1968 ◽  
Vol 2 (5603) ◽  
pp. 472-473 ◽  
Author(s):  
F. F. Fenech ◽  
N. G. Soler

Sign in / Sign up

Export Citation Format

Share Document